Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

NACompletedINTERVENTIONAL
Enrollment

29,607

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Hepatitis CChronic Hepatitis C
Interventions
OTHER

Mailer

Henry Ford intentifies patients meeting birth cohort screening criteria and then sends mailers to those individuals. Mailers contained HCV guidelines, the importance of screening, laboratory slips and locations for patients to act directly on their own behalf. If patients do not respond to the initial mailer, Henry Ford sends additional mailers.

OTHER

In-person recruitment

UAB used study coordinators to actively screen and recruit patients who met the inclusion criteria for birth-cohort screening. Study coordinators were located at two internal medicine clinics, where they approached eligible participants in person. A control group was pulled from an additional two internal medicine clinics, which screened using a risk-based strategy. A cross-over approach was used, so that the intervention and control clinics switched at the midpoint of data collection, allowing all four clinics to participate in both arms of the study.

OTHER

EHR Alert

EHR include a Best Practice Alert (BPA) prompting the Medical Assistant and/or clinican to order a Hepatitis C lab test for patients in the birth cohort.

Trial Locations (3)

10029

Mt. Sinai Medical Center, New York

35294

University of Alabama, Birmingham, Birmingham

48202

Henry Ford Health System, Detroit

All Listed Sponsors
collaborator

NORC at the University of Chicago

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Henry Ford Health System

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

National Opinion Research Center

OTHER

NCT02123212 - Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C | Biotech Hunter | Biotech Hunter